• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Atopic dermatitis may be more persistent than previously understood

byShirin BajajandAdam Whittington
April 7, 2014
in Chronic Disease, Dermatology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

Image: PD

1. Patients who were diagnosed with mild to moderate atopic dermatitis (AD) within the first few years of life were likely to have persistent disease into their second decade. 

2. Factors including history of atopic illness, household income<$50,000, seasonal allergies, household pet allergies and allergies to common foods and medications were associated with more persistent disease. 

Evidence Rating Level: 1 (Excellent) 

Study Rundown: Atopic Dermatitis (AD) is a common disease in early childhood, and may cause a high morbidity.  This study analyzed the Pediatric Eczema Elective Registry (PEER) in an attempt to better understand the natural history of patients with AD.  Whereas previous studies have proven 50-70% of patients will achieve remission of their AD by age 12, this study showed high likelihood of persistence of disease into the second decade of life. This study’s strengths are the unprecedented very large cohort and the design to re-evaluate patients longitudinally through many years of follow-up. The study is limited by the inclusion criteria, which incorporated only patients that already required topical treatment, which selects for a pool of patients that have more severe disease at baseline. Additionally, it’s possible that patients with greater burden of disease were more likely to fill out and return surveys.

Click to read the study in JAMA Dermatology

RELATED REPORTS

Use of psychiatric medications may be associated with a higher risk of amyotrophic lateral sclerosis

Nivolumab plus ipilimumab improves survival over lenvatinib or sorafenib in liver cancer

Dapagliflozin may improve outcomes in patients with metabolic dysfunction-associated steatohepatitis

Relevant Reading: Atopic Dermatitis and the Atopic March

In-Depth [prospective cohort]: From the 7157 patients in the PEER registry, surveys assessed whether during the past 6-months, their rash from AD had ever cleared completely, and whether they had used topical treatment. Between ages 2-26, at every age group, 80% of patients with mild to moderate atopic dermatitis (AD) had symptoms of AD. Additionally, 64% of patients who had followed-up for 5-years never reported a 6-month period without disease. Authors also analyzed risk factors for any 6-month symptom and treatment-free period using t and Χ2 testing and random-intercept logistic regression. Multiple demographic and environmental exposures were associated with more persistent disease including seasonal allergies, medication allergies and food allergies (Adjusted OR: 0.81, 1.18, and 0.63, respectively). Kaplan Meier plots illustrated the proportion of the study population that was symptom-free for 6 months. Using this analysis and area under the receiver operating curve, prognostic models were developed to depict persistent symptoms of AD past the first decade of life.

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Previous Post

Roadway design may decrease risk of child pedestrian collisions

Next Post

QI methods improve adherence to PALS sepsis guidelines

RelatedReports

Quick Take: The clinical effectiveness of sertraline in primary care and the role of depression severity and duration (PANDA): a pragmatic, double-blind, placebo-controlled randomized trial
Chronic Disease

Use of psychiatric medications may be associated with a higher risk of amyotrophic lateral sclerosis

June 12, 2025
Prognostic indicators for transarterial chemoembolization in patients with hepatocellular carcinoma with extrahepatic spread identified
AI Roundup

Nivolumab plus ipilimumab improves survival over lenvatinib or sorafenib in liver cancer

June 12, 2025
Intrapartum serum prolactin may predict risk of postpartum diabetes
Chronic Disease

Dapagliflozin may improve outcomes in patients with metabolic dysfunction-associated steatohepatitis

June 11, 2025
Late gestation antidepressant use linked to postpartum hemorrhage
Obstetrics

Early induction of labour reduces shoulder dystocia rates in large for gestational age fetuses

June 11, 2025
Next Post
Discharge diagnoses in the E.R. cannot retrospectively identify non-emergent visits

QI methods improve adherence to PALS sepsis guidelines

Nonleg venous thromboses associated with PE, longer ICU stay

2 Minute Medicine Rewind March 31- April 7th, 2014

Women electing abortion more likely to be victims of domestic violence

Low-dose aspirin may reduce risk of preeclampsia

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Use of psychiatric medications may be associated with a higher risk of amyotrophic lateral sclerosis
  • Nivolumab plus ipilimumab improves survival over lenvatinib or sorafenib in liver cancer
  • Dapagliflozin may improve outcomes in patients with metabolic dysfunction-associated steatohepatitis
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.